ARIE S. BELLDEGRUN

Profile

First Name

: ARIE

Middle Name

: S.

Last Name

: BELLDEGRUN

Related Companies
Titles
Company Name
Related People
DIRECTOR
ARNO THERAPEUTICS, INC
ARIE S. BELLDEGRUN, M.D., ROBERT I. FALK, WILLIAM F. HAMILTON, WILLIAM F. HAMILTON, PH.D., TOMER KARIV, PETER M. KASH, JOSHUA A. KAZAM, GLENN R. MATTES, JAY MOORIN, SCOTT L. NAVINS, STEFAN PRONIUK, PH.D., YACOV REIZMAN, STEVEN B. RUCHEFSKY, DAVID M. TANEN, RANDY H. THURMAN, ALEXANDER ZUKIWSKI, M.D.
DIRECTOR, EXECUTIVE OFFICER
KITE PHARMA, INC.
MARC BETTER, DAVID BONDERMAN, CYNTHIA M. BUTITTA, FARAH CHAMPSI, ROY DOUMANI, AYA JAKOBOVITS, JOSHUA A. KAZAM, GLORIA LEE, KEITH NOLOP, RAN NUSSBAUM, JONATHAN M. PEACOCK, MARGO R. ROBERTS, STEVEN B. RUCHEFSKY, RIZWANA SPROULE
DIRECTOR
NILE THERAPEUTICS, INC.
DEBORAH ASCHEIM, ANTHONY BERGMANN, RICHARD B. BREWER, EARL COLLIER, EARL COLLIER, JR., ANTHONY DAVIES, GEORGE DUNBAR, DARON EVANS, LELAND GERSHELL, PEDRO GRANADILLO, LOUIS GRASMICK, ANDREW HAMER, PETER M. KASH, JOSHUA KAZAM, JOSHUA A KAZAM, JOSHUA A. KAZAM, KAREN KRASNEY, HSIAO D. LIEU, FRANK LITVACK, LOUIS MANZO, LINDA MARBAN, PAUL A. MIEYAL, PAUL A. MIEYAL, PH.D., DAVID MUSKET, GREGORY SCHAFER, GREGORY W. SCHAFER, RACHEL SMITH, DAVID M. TANEN
DIRECTOR
BYHEART, INC.
ELIZABETH ABRAMS, ELIAS AOUKAR, JAMES E. BAUERSMITH, ARIE BELLDEGRUN, RON BELLDEGRUN, JOSHUA BRADLEY, TOMMY BURKE, MIA B. FUNT, JOSHUA KAZAM, JOSHUA A. KAZAM, GEORG KRAUSE-VILMAR, DEVON KUEHN, ANTON LINDERUM, ANTON H. LINDERUM, NIALL MULLANE, GUY ORANIM, ROBERT PERUZZI, AMY SCHULMAN, ALLAN SEBBAG, DENICE TORRES, MICHAEL TULLY, SALONI VARMA, RAPHAEL WALLANDER, HEMI ZUCKER
DIRECTOR, PROMOTER
ICONOVIR BIO, INC.
SEAN ALGEO, DAVID CHANG, JOHN HUYNH, WILLIAM KAELIN, JOSHUA KAZAM, JOSHUA A. KAZAM, HELEN S. KIM, JAKOB LOVEN, JULIE MALTZMAN, MARK A. MCCAMISH, HEBA NOWYHED, DAVID M. TANEN, NICOLE VAN DE LEUV
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-04-08
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2024-03-28 
2023-06-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-06-06 
2023-01-13
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2022-12-30 
2021-07-29
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2021-07-09 
2021-07-27
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2021-07-09 
2020-12-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-01 
2020-04-01
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2020-03-18 
2014-05-02
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2014-04-25 
2013-05-24
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-10 
2012-12-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2012-11-30 
2011-06-27
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2011-06-20 
2011-03-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2011-02-25 
2010-09-23
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2010-09-09